EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study

Mattia Lo Re, Paolo Polverino, Anna Rivetti, Alessio Pecoraro, Marco Saladino, Marta Pezzoli, Giampaolo Siena, Cosimo De Nunzio, Vincenzo Li Marzi, Mauro Gacci, Sergio Serni, Riccardo Campi und 1 weitere

World Journal of Urology · 10.07.2024 · 42 (1)

DOI: 10.1007/s00345-024-05077-z ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, online erschienen am 10.07.2024. Verfasst von Mattia Lo Re und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, 50100, Italy. mattia.lore@unifi.it. Hauptthemen laut MEDLINE: Prostatic Hyperplasia, Laser Therapy. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Firenze.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Transperineal laser ablation (TPLA) is a new minimally-invasive surgical treatment for patients with benign prostatic obstruction (BPO). We report the perioperative and mid-term functional results of the first 100 consecutively patients undergoing TPLA at our institution.

Methods

Clinical data from consecutive patients undergoing TPLA at our institution from April 2021 to July 2023 were prospectively collected. Primary endpoints were the postoperative changes in IPSS, QoL and MSHQ 3-item questionnaires and in Qmax and post-void residual volume (PVR).

Results

Overall, 100 consecutive patients underwent the procedure. Median age and prostate volume were 66 (IQR 60–75) years and 50 (IQR 40–70) ml, respectively. In the cohort, 14 (14%) patients had an indwelling catheter and 81 (81%) were under oral BPO therapy at the time of TPLA. Baseline median Qmax (ml/s) and PVR (ml) were 9.1 (IQR 6.9–12) and 90 (IQR 50–150), respectively, while median IPSS and QoL were 18 (IQR 15–23) and 4 (IQR 3–4). At all the follow-up timepoints, the evaluated outcomes on both symptoms and functional parameters showed a statistically significant improvement ( p < 0.001). Antegrade ejaculation was preserved in all sexually active patients. No postoperative Clavien-Dindo > 2 complications were recorded.

Conclusions

TPLA represents a safe option for selected well-informed patients swith LUTS due to BPO. Our prospective study confirms the feasibility and favorable perioperative and functional outcomes in a real-world cohort with heterogenous prostate volumes and patient characteristics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic HyperplasiaLaser TherapyHumansMaleAgedMiddle AgedProspective StudiesTreatment OutcomePerineumCohort Studies

Stichwörter der Autor:innen

Benign prostatic hyperplasiaEjaculation sparingLower urinary tract symptomsTransperineal laser ablation of the prostateUltra-minimally invasive surgical techniques

Autor:innen und Institutionen

  • Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, 50100, Italy. mattia.lore@unifi.it.
  • Unit of Oncologic Minimally Invasive Urology and Andrology, University of Florence, Careggi Hospital, Florence, 50100, Italy. mattia.lore@unifi.it.
  • Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. mattia.lore@unifi.it.
  • Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, 50100, Italy.
  • Unit of Oncologic Minimally Invasive Urology and Andrology, University of Florence, Careggi Hospital, Florence, 50100, Italy.
  • Department of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy.

Förderung

  • Università degli Studi di Firenze

Zitieren

APA

Lo Re, M., Polverino, P., Rivetti, A., Pecoraro, A., Saladino, M., Pezzoli, M., Siena, G., De Nunzio, C., Li Marzi, V., Gacci, M., Serni, S., Campi, R., & Sessa, F. (2024). Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-05077-z

Vancouver

Lo Re M, Polverino P, Rivetti A, Pecoraro A, Saladino M, Pezzoli M, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-05077-z

BibTeX
@article{LoRe2024,
  author = {Lo Re, Mattia and Polverino, Paolo and Rivetti, Anna and Pecoraro, Alessio and Saladino, Marco and Pezzoli, Marta and Siena, Giampaolo and De Nunzio, Cosimo and Li Marzi, Vincenzo and Gacci, Mauro and Serni, Sergio and Campi, Riccardo and Sessa, Francesco},
  title = {Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study},
  journal = {World Journal of Urology},
  year = {2024},
  volume = {42},
  number = {1},
  doi = {10.1007/s00345-024-05077-z}
}
Kostenlos starten →